Archer Materials Ltd
(ASX:AXE)Share Price and News
About Archer Materials
Archer is developing two technologies – 12CQ and Biochip. 12CQ is a carbon-based quantum bit (qubit) semiconductor technology. Once fully developed, the technology may potentially enable quantum devices that process quantum information in mobile technology and be accessible to a more broader population than today.
Biochip is a Lab-on-a-Chip technology being developed to enable rapid, parallelised detection of diseases. It would allow droplets of biological specimens to be analysed and processed using graphene sensors.
Archer Materials Company History
Archer Materials started its journey in 2007 as an Australian mineral exploration company digging for graphite. But a few years later, it struck a different kind of gold: a breakthrough in room-temperature quantum computing.
This discovery changed everything. Between 2016-2019, Archer pivoted hard, spinning off its mineral assets into iTech Minerals so it could go all-in on quantum tech and biochips.
Since then, it has worked hard at Biochip and 12CQ. Although commercialisation of 12CQ is realistically 5-7 years away, there are development milestones to be achieved before then that could be accretive to shareholder value for Archer investors. Biochip, meanwhile, could be commercialised earlier.
Future Outlook of Archer Materials Ltd (ASX:AXE)
Archer Materials has several major goals for 2025. These include:
- Continuing to refine 12CQ and Biochip, particularly progressing the control and readout functionality, and design fabrication;
- Identifying other technologies and devices that might be suitable for 12CQ
- Procuring new commercial partnerships and advancing existing ones, and
- Developing TMR (tunnel magnetoresistance) sensors for commercial use in industrial applications.
Is Archer Materials a Good Stock to Buy?
Archer's progress with quantum chips and biochip tech, combined with their healthy finances, make them a compelling option for investors who want to make a high-risk, high-reward play.
But of course, it is a high-risk company that is a few years away from commercialisation, so investors should proceed with caution.
Our Stock Analysis
Mark the Pitt Street Research Semiconductor Conference 2025 in your calendars!
The Pitt Street Research Semiconductor Conference 2025 is coming up! Pitt Street Research in partnership with Bell Potter are thrilled…
Here’s what 2025 holds for Archer Materials (ASX:AXE) and why investors should be excited
Let’s take a look at what 2025 holds for Archer Materials (ASX:AXE), a company that is making a steady journey…
Here’s why you should attend Semiconductor Australia 2024 – Australia’s premier semiconductor industry event
In 3 weeks time, on 24 October, Semiconductor Australia 2024 will take place in Sydney. Hosted by BluGlass, Sharecafe and…
Archer Materials (ASX:AXE), the ASX’s only quantum computing stock, has made progress in the last 12 months
Archer Materials (ASX:AXE) has garnished significant investor attention as ASX’s only quantum computing stock. It has been a rollercoaster ride…
Archer Materials (ASX:AXE): There’s more to the company than many investors think
Archer Materials (ASX:AXE) has long attracted intrigue as the only ASX company in quantum computing, although there is far more…
TSMC: The TW$13tn company that’s the reason why China has an eager eye on Taiwan
Have you ever heard of TSMC (Taiwan Semiconductor Manufacturing Company)? If you haven’t, there are good reasons why you should…
Frequently Asked Questions
Archer has 12CQ, a technology that could enable room-temperature quantum computing, and "Biochip" which is a Lab-on-a-Chip technology being developed to enable rapid, detection of diseases.